| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $9.1B | $7.0B | $5.2B | $4.1B | $3.1B | $0.7B | $0.7B | $0.6B |
| Cost of Revenue | $6.9B | $5.6B | $4.2B | $3.4B | $2.5B | $2.3B | $2.1B | $1.7B |
| Gross Profit | $2.2B | $1.5B | $1.0B | $0.7B | $0.6B | $0.1B | $0.1B | $0.1B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $0.9B | $0.7B | $0.6B | $0.5B | $0.4B | $0.4B | $0.3B | $0.3B |
| Operating Income | $1.3B | $0.7B | $0.4B | $0.3B | $0.2B | $0.2B | $0.2B | $0.2B |
| Net Income | $1.0B | $0.5B | $0.3B | $0.2B | $0.1B | $0.0B | $0.0B | $0.0B |
| EPS (Basic) | $28.93 | $14.64 | $9.03 | $6.84 | $3.95 | $1.18 | $0.93 | $0.68 |
| EPS (Diluted) | $28.88 | $14.60 | $9.01 | $6.82 | $3.93 | $1.17 | $0.92 | $0.67 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $6.4B | $4.7B | $3.3B | $2.6B | $2.2B | $1.8B | $1.5B | $1.1B |
| Current Assets | $4.1B | $2.8B | $1.9B | $1.3B | $1.0B | $0.8B | $0.8B | $0.6B |
| Cash & Equivalents | $1.0B | $0.5B | $0.2B | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B |
| Total Liabilities | $4.0B | $3.0B | $2.0B | $1.6B | $1.4B | $1.1B | $0.9B | $0.6B |
| Current Liabilities | $3.4B | $2.6B | $1.7B | $1.2B | $0.8B | $0.7B | $0.6B | $0.5B |
| Stockholders' Equity | $2.4B | $1.7B | $1.3B | $1.0B | $0.8B | $0.7B | $0.6B | $0.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.2B | $0.8B | $0.6B | $0.3B | $0.2B | $0.3B | $0.1B | $0.1B |
| Investing Cash Flow | $-0.5B | $-0.3B | $-0.2B | $-0.1B | $-0.2B | $-0.2B | $-0.2B | $-0.1B |
| Capital Expenditures | $0.2B | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $-0.3B | $-0.2B | $-0.3B | $-0.2B | $0.1B | $-0.1B | $0.1B | $-0.0B |